ID   85As2mLuc
AC   CVCL_D5HW
DR   JCRB; JCRB1953
DR   JCRB; NIHS1340
DR   Wikidata; Q127378796
RX   PubMed=23659450;
CC   Population: Japanese.
CC   Characteristics: Metastatic and cachexia-inducing (PubMed=23659450).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg110Cys (c.328C>T); ClinVar=VCV000142206; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Firefly luciferase.
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Discontinued: JCRB; NIHS1340; true.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): JCRB=JCRB1953
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 10
ST   D5S818: 10,11
ST   D7S820: 10,11
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 19
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D5HV ! 85As2
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
RX   PubMed=23659450; DOI=10.1080/01635581.2013.776089;
RA   Yanagihara K., Takigahira M., Mihara K., Kubo T., Morimoto C.,
RA   Morita Y., Terawaki K., Uezono Y., Seyama T.;
RT   "Inhibitory effects of isoflavones on tumor growth and cachexia in
RT   newly established cachectic mouse models carrying human stomach
RT   cancers.";
RL   Nutr. Cancer 65:578-589(2013).
//